|
1
|
Weller M, Pfister SM, Wick W, Hegi ME,
Reifenberger G and Stupp R: Molecular neuro-oncology in clinical
practice: A new horizon. Lancet Oncol. 14:e370–e379. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen PY and Kesari S: Malignant gliomas in
adults. New Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nutt CL, Mani DR, Betensky RA, Tamayo P,
Cairncross JG, Ladd C, Pohl U, Hartmann C, Mclaughlin ME, Batchelor
TT, et al: Gene expression-based classification of malignant
gliomas correlates better with survival than histological
classification. Cancer Res. 63:1602–1607. 2003.PubMed/NCBI
|
|
5
|
Nayak L and Reardon DA: High-Grade
gliomas. Continuum (Minneap Minn). 23:1548–1563. 2017.PubMed/NCBI
|
|
6
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. New Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khasraw M and Lassman AB: Advances in the
treatment of malignant gliomas. Curr Oncol Rep. 12:26–33. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cohen AL and Colman H: Glioma biology and
molecular markers. Cancer Treat Res. 163:15–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kros JM, Mustafa DM, Dekker LJ, Sillevis
Smitt PA, Luider TM and Zheng PP: Circulating glioma biomarkers.
Neuro Oncol. 17:343–360. 2015.PubMed/NCBI
|
|
10
|
Hirokawa N and Tanaka Y: Kinesin
superfamily proteins (KIFs): Various functions and their relevance
for important phenomena in life and diseases. Exp Cell Res.
334:16–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hirokawa N, Bloom GS and Vallee RB:
Cytoskeletal architecture and immunocytochemical localization of
microtubule-associated proteins in regions of axons associated with
rapid axonal transport: The beta,
beta′-iminodipropionitrile-intoxicated axon as a model system. J
Cell Biol. 101:227–239. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirokawa N, Niwa S and Tanaka Y: Molecular
motors in neurons: Transport mechanisms and roles in brain
function, development, and disease. Neuron. 68:610–638. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okada Y, Yamazaki H, Sekine-Aizawa Y and
Hirokawa N: The neuron-specific kinesin superfamily protein KIF1A
is a unique monomeric motor for anterograde axonal transport of
synaptic vesicle precursors. Cell. 81:769–780. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ari C, Borysov SI, Wu J, Padmanabhan J and
Potter H: Alzheimer amyloid beta inhibition of Eg5/kinesin 5
reduces neurotrophin and/or transmitter receptor function.
Neurobiol Aging. 35:1839–1849. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mcguire JR, Rong J, Li SH and Li XJ:
Interaction of huntingtin- associated protein-1 with kinesin light
chain: Implications in intracellular trafficking in neurons. J Biol
Chem. 281:3552–3559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang W, Tanaka Y, Bundo M and Hirokawa N:
Antioxidant signaling involving the microtubule motor KIF12 is an
intracellular target of nutrition excess in beta cells. Dev Cell.
31:202–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mrug M, Li R, Cui X, Schoeb TR, Churchill
GA and Guay-Woodford LM: Kinesin family member 12 is a candidate
polycystic kidney disease modifier in the cpk mouse. J Am Soc
Nephrol. 16:905–916. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mazumdar M, Lee JH, Sengupta K, Ried T,
Rane S and Misteli T: Tumor formation via loss of a molecular motor
protein. Curr Biol. 16:1559–1564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chandrasekaran G, Tátrai P and Gergely F:
Hitting the brakes: Targeting microtubule motors in cancer. Br J
Cancer. 113:693–698. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang W, Shi Y, Li J, Cui W and Yang B:
Up-Regulation of KIF14 is a predictor of poor survival and a novel
prognostic biomarker of chemoresistance to paclitaxel treatment in
cervical cancer. Bioscience Rep. 36:e3152016. View Article : Google Scholar
|
|
21
|
Sturgill EG, Norris SR, Guo Y and Ohi R:
Kinesin-5 inhibitor resistance is driven by kinesin-12. J Cell
Biol. 213:213–227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Guo X, Xie C and Jiang J: KIF15
promotes pancreatic cancer proliferation via the MEK-ERK signalling
pathway. Brit J Cancer. 117:245–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Milic B, Chakraborty A, Han K, Bassik MC
and Block SM: KIF15 nanomechanics and kinesin inhibitors, with
implications for cancer chemotherapeutics. Proc Natl Acad Sci USA.
115:E4613–E4622. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pollack IF, Finkelstein SD, Woods J,
Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL,
Sposto R, et al: Expression of p53 and prognosis in children with
malignant gliomas. New Engl J Med. 346:420–427. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Omuro A and Deangelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tafani M, De Vito M, Frati A, Pellegrini
L, De Santis E, Sette G, Eramo A, Sale P, Mari E, Santoro A, et al:
Pro-inflammatory gene expression in solid glioblastoma
microenvironment and in hypoxic stem cells from human glioblastoma.
J Neuroinflamm. 8:322011. View Article : Google Scholar
|
|
27
|
Sampson JH, Choi BD, Sanchez-Perez L,
Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap
EA, Norberg PK, et al: EGFRvIII mCAR-modified T-cell therapy cures
mice with established intracerebral glioma and generates host
immunity against tumor-antigen loss. Clin Cancer Res. 20:972–984.
2016. View Article : Google Scholar
|
|
28
|
Yan Z, Wang J, Wang C, Jiao Y, Qi W and
Che S: MiR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes
glioma growth. FEBS Lett. 588:3038–3046. 2016. View Article : Google Scholar
|
|
29
|
Wykosky J, Gibo DM, Stanton C and Debinski
W: Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen
1 as molecular denominators of high-grade astrocytomas and specific
targets for combinatorial therapy. Clin Cancer Res. 14:199–208.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han Y, Wu Z, Wu T, Huang Y, Cheng Z, Li X,
Sun T, Xie X, Zhou Y and Du Z: Tumor-suppressive function of long
noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and
inactivation of ERK/MAPK signaling. Cell Death Dis. 7:e21232016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao S, Wang Y, Li J, Lv M, Niu H and Tian
Y: Tumor-suppressive function of long noncoding RNA MALAT1 in
glioma cells by suppressing miR-155 expression and activating FBXW7
function. Am J Cancer Res. 6:2561–2574. 2016.PubMed/NCBI
|
|
32
|
Wang J, Ma S, Ma R, Qu X, Liu W, Lv C,
Zhao S and Gong Y: KIF2A silencing inhibits the proliferation and
migration of breast cancer cells and correlates with unfavorable
prognosis in breast cancer. BMC Cancer. 14:4612014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iltzsche F, Simon K, Stopp S, Pattschull
G, Francke S, Wolter P, Hauser S, Murphy DJ, Garcia P, Rosenwald A
and Gaubatz S: An important role for Myb-MuvB and its target gene
KIF23 in a mouse model of lung adenocarcinoma. Oncogene.
36:110–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Venere M, Horbinski C, Crish JF, Jin X,
Vasanji A, Major J, Burrows AC, Chang C, Prokop J, Wu Q, et al: The
mitotic kinesin KIF11 is a driver of invasion, proliferation, and
self-renewal in glioblastoma. Sci Transl Med. 7:143r–304r. 2015.
View Article : Google Scholar
|
|
35
|
Matsuda M, Yamamoto T, Matsumura A and
Kaneda Y: Highly efficient eradication of intracranial glioblastoma
using Eg5 siRNA combined with HVJ envelope. Gene Ther.
16:1465–1476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Exertier P, Javerzat S, Wang B, Franco M,
Herbert J, Platonova N, Winandy M, Pujol N, Nivelles O and Ormenese
S: Impaired angiogenesis and tumor development by inhibition of the
mitotic kinesin Eg5. Oncotarget. 4:2302–2316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen S, Han M, Chen W, He Y, Huang B, Zhao
P, Huang Q, Gao L, Qu X and Li X: KIF1B promotes glioma migration
and invasion via cell surface localization of MT1-MMP. Oncol Rep.
35:971–977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu M, Nadar VC, Kozielski F, Kozlowska M,
Yu W and Baas PW: Kinesin-12, a mitotic microtubule-associated
motor protein, impacts axonal growth, navigation and branching. J
Neurosci. 30:14896–14906. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu M, Liu D, Dong Z, Wang X, Wang X, Liu
Y, Baas PW and Liu M: Kinesin-12 influences axonal growth during
zebrafish neural development. Cytoskeleton (Hoboken). 71:555–563.
2015. View Article : Google Scholar
|
|
40
|
Scanlan MJ, Gout I, Gordon CM, Williamson
B, Stockert E, Gure AO, Jäger D, Chen YT, Mackay A, O'Hare MJ and
Old LJ: Humoral immunity to human breast cancer: Antigen definition
and quantitative analysis of mRNA expression. Cancer Immun.
1:42001.PubMed/NCBI
|
|
41
|
Zou JX, Duan Z, Wang J, Sokolov A, Xu J,
Chen CZ, Li JJ and Chen HW: Kinesin family deregulation coordinated
by bromodomain protein ANCCA and histone methyltransferase MLL for
breast cancer cell growth, survival, and tamoxifen resistance. Mol
Cancer Res. 12:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bidkhori G, Narimani Z, Hosseini Ashtiani
S, Moeini A, Nowzari-Dalini A and Masoudi-Nejad A: Reconstruction
of an integrated genome-scale co-expression network reveals key
modules involved in lung adenocarcinoma. PLoS One. 8:e675522013.
View Article : Google Scholar : PubMed/NCBI
|
